23.91
0.40%
0.0923
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $23.91, with a volume of 5.78M.
It is up +0.40% in the last 24 hours and up +10.11% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
See More
Previous Close:
$23.82
Open:
$23.805
24h Volume:
5.78M
Relative Volume:
0.40
Market Cap:
$45.67B
Revenue:
$15.46B
Net Income/Loss:
$1.06B
P/E Ratio:
48.21
EPS:
0.496
Net Cash Flow:
$1.40B
1W Performance:
+0.57%
1M Performance:
+10.11%
6M Performance:
+16.83%
1Y Performance:
+21.52%
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
199 GRANDVIEW ROAD, SKILLMAN
Compare KVUE with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
KVUE | 23.91 | 45.67B | 15.46B | 1.06B | 1.40B | 0.496 |
PG | 170.91 | 400.11B | 83.91B | 14.32B | 15.85B | 6.16 |
UL | 57.94 | 143.03B | 64.93B | 7.15B | 0 | 3.4285 |
CL | 94.94 | 76.44B | 20.11B | 2.87B | 3.40B | 1.92 |
KMB | 135.86 | 44.84B | 20.10B | 2.61B | 2.90B | 5.20 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-24-24 | Initiated | Jefferies | Buy |
Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
May-28-24 | Resumed | Citigroup | Neutral |
Apr-11-24 | Initiated | Bernstein | Underperform |
Apr-03-24 | Initiated | William Blair | Mkt Perform |
Mar-01-24 | Resumed | Goldman | Neutral |
Nov-17-23 | Initiated | Piper Sandler | Neutral |
Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
Sep-07-23 | Initiated | Canaccord Genuity | Buy |
Sep-06-23 | Initiated | Argus | Hold |
Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
Jul-25-23 | Initiated | Edward Jones | Buy |
Jun-01-23 | Initiated | HSBC Securities | Hold |
May-30-23 | Initiated | BofA Securities | Buy |
May-30-23 | Initiated | Citigroup | Neutral |
May-30-23 | Initiated | Deutsche Bank | Hold |
May-30-23 | Initiated | Exane BNP Paribas | Neutral |
May-30-23 | Initiated | Goldman | Neutral |
May-30-23 | Initiated | JP Morgan | Overweight |
May-30-23 | Initiated | RBC Capital Mkts | Outperform |
May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue Appoints Publicis Media As Agency In APAC - Marketing Strategy, Brands ...
LMR Partners LLP Sells 4,026,266 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
AMG National Trust Bank Has $6.48 Million Stake in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Inc. (NYSE:KVUE) Position Boosted by Thrivent Financial for Lutherans - MarketBeat
Natixis Advisors LLC Has $41.01 Million Stock Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
24,054 Shares in Kenvue Inc. (NYSE:KVUE) Acquired by Atlanta Consulting Group Advisors LLC - MarketBeat
Kenvue concludes its APAC media pitch; appoints Publicis Media as its agency - Storyboard18
When (KVUE) Moves Investors should Listen - Stock Traders Daily
Victory Capital Management Inc. Has $30.72 Million Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Mizuho Markets Americas LLC Buys 1,489,647 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
KBC Group NV Boosts Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue stock hits 52-week high at $23.96 amid robust growth - Investing.com Australia
Kenvue Inc. (NYSE:KVUE) Short Interest Update - MarketBeat
Kenvue stock hits 52-week high at $23.96 amid robust growth By Investing.com - Investing.com South Africa
There May Be Reason For Hope In Kenvue's (NYSE:KVUE) Disappointing Earnings - Yahoo Finance
ING Groep NV Increases Stake in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Curi RMB Capital LLC Sells 530,315 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Increases Stake in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Saturna Capital Corp Increases Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
FMR LLC's Strategic Acquisition of Kenvue Inc Shares - GuruFocus.com
Kenvue's SWOT analysis: consumer health stock faces challenges, opportunities - Investing.com
Kenvue innovations: 3 products for conditioning hair, pain relief and improving appearance of skin during menopause - Marketscreener.com
Kenvue’s Weak Sales Give Power to Activist Push - MSN
Kenvue updates organic revenue outlook as Q3 revenue misses estimates - MSN
Kenvue : 4 Kenvue clinical studies that helped us earn trust with science - Marketscreener.com
Kenvue (NYSE:KVUE) Sets New 52-Week HighTime to Buy? - MarketBeat
Ex-Dividend Reminder: PACCAR, Cheesecake Factory and Kenvue - Nasdaq
XML Financial LLC Takes $640,000 Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Principal Financial Group Inc. Acquires 73,542 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Tyler Stone Wealth Management Has $1.14 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Troy Asset Management Ltd Sells 114,561 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue (NYSE:KVUE) Issues Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Concurrent Investment Advisors LLC Has $1.24 Million Stake in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Inc. (NYSE:KVUE) Stock Position Reduced by Robeco Institutional Asset Management B.V. - MarketBeat
Kenvue misses quarterly sales estimates as skincare sales decline - MSN
Kenvue Names Andrew Stanleick President of Skin Health & Beauty - Happi
Easterly Investment Partners LLC Sells 433,345 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Inc. (NYSE:KVUE) Q3 2024 Earnings Call Transcript - MSN
Kenvue Inc (KVUE) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Market Challenges By GuruFocus - Investing.com Canada
Kenvue: Q3 Earnings Snapshot - CT Insider
Kenvue Reports Third Quarter 2024 Financial Results - TipRanks
Kenvue misses quarterly sales estimates on sluggish skincare sales - WKZO
Kenvue's falling skin health sales hit earnings again - MSN
Tylenol maker Kenvue expands manufacturing facility in Guelph - Samfiru Tumarkin LLP
Neutrogena parent Kenvue Q3 sales decrease 0.4% - FashionNetwork.com
Kenvue Inc. (KVUE): Expanded Production and Trusted Brands Drive Growth - Insider Monkey
Kenvue (KVUE) Q3 2024 Earnings Call Transcript - The Motley Fool
Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty Sales - AOL
Tylenol maker Kenvue hails efficiency gains as activist Starboard watches on - Proactive Investors USA
EXCLUSIVE: Andrew Stanleick Joins Kenvue - MSN
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):